BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12506074)

  • 21. Pseudomonas aeruginosa proteases and corneal virulence.
    Hobden JA
    DNA Cell Biol; 2002; 21(5-6):391-6. PubMed ID: 12167241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of clinical characteristics and antibiotic susceptibility between Pseudomonas aeruginosa and P. putida keratitis at a tertiary referral center: a retrospective study.
    Cho CH; Lee SB
    BMC Ophthalmol; 2018 Aug; 18(1):204. PubMed ID: 30126384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A substitution at His-120 in the LasA protease of Pseudomonas aeruginosa blocks enzymatic activity without affecting propeptide processing or extracellular secretion.
    Gustin JK; Kessler E; Ohman DE
    J Bacteriol; 1996 Nov; 178(22):6608-17. PubMed ID: 8932318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pseudomonas aeruginosa protease IV: a corneal virulence factor of low immunogenicity.
    Thibodeaux BA; Caballero AR; Dajcs JJ; Marquart ME; Engel LS; O'Callaghan RJ
    Ocul Immunol Inflamm; 2005; 13(2-3):169-82. PubMed ID: 16019676
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protease IV, a unique extracellular protease and virulence factor from Pseudomonas aeruginosa.
    Engel LS; Hill JM; Caballero AR; Green LC; O'Callaghan RJ
    J Biol Chem; 1998 Jul; 273(27):16792-7. PubMed ID: 9642237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of virulence factors, antimicrobial resistance patterns and biofilm formation of Pseudomonas aeruginosa and Staphylococcus spp. strains isolated from corneal infection.
    Heidari H; Hadadi M; Sedigh Ebrahim-Saraie H; Mirzaei A; Taji A; Hosseini SR; Motamedifar M
    J Fr Ophtalmol; 2018 Nov; 41(9):823-829. PubMed ID: 30292385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of type IV pilus genes in plant growth-promoting Pseudomonas putida WCS358.
    de Groot A; Heijnen I; de Cock H; Filloux A; Tommassen J
    J Bacteriol; 1994 Feb; 176(3):642-50. PubMed ID: 7905475
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    O'Callaghan R; Caballero A; Tang A; Bierdeman M
    Microorganisms; 2019 Aug; 7(9):. PubMed ID: 31443433
    [No Abstract]   [Full Text] [Related]  

  • 29. Detection of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens-associated corneal ulcers.
    Pinna A; Usai D; Sechi LA; Molicotti P; Zanetti S; Carta A
    Cornea; 2008 Apr; 27(3):320-6. PubMed ID: 18362661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics, isolation and role in the infectious process of Pseudomonas aeruginosa protease.
    Brodinova NS; Moroz AF; Luchina TYa
    J Hyg Epidemiol Microbiol Immunol; 1983; 27(1):69-76. PubMed ID: 6406591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purification of Pseudomonas aeruginosa proteases and microscopic characterization of pseudomonal protease-induced rabbit corneal damage.
    Kreger AS; Gray LD
    Infect Immun; 1978 Feb; 19(2):630-48. PubMed ID: 415981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of pseudomonal ulceration in rabbit corneas by a synthetic matrix metalloproteinase inhibitor.
    Barletta JP; Angella G; Balch KC; Dimova HG; Stern GA; Moser MT; van Setten GB; Schultz GS
    Invest Ophthalmol Vis Sci; 1996 Jan; 37(1):20-8. PubMed ID: 8550324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of adhesion, piliation, protease production and ocular infectivity of several P. aeruginosa strains.
    Hazlett LD; Moon MM; Singh A; Berk RS; Rudner XL
    Curr Eye Res; 1991 Apr; 10(4):351-62. PubMed ID: 1676963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Degradation of uniquely glycosylated secretory immunoglobulin a in tears from patients with Pseudomonas aeruginosa keratitis.
    Lomholt JA; Kilian M
    Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4939-44. PubMed ID: 18757515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of
    Caballero AR; Tang A; Bierdeman M; O'Callaghan R; Marquart M
    Curr Eye Res; 2021 May; 46(5):638-647. PubMed ID: 32938252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alleviation of Pseudomonas aeruginosa Infection by Propeptide-Mediated Inhibition of Protease IV.
    Kim TH; Li XH; Lee JH
    Microbiol Spectr; 2021 Oct; 9(2):e0078221. PubMed ID: 34704789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pseudomonas aeruginosa alkaline protease: evidence for secretion genes and study of secretion mechanism.
    Guzzo J; Pages JM; Duong F; Lazdunski A; Murgier M
    J Bacteriol; 1991 Sep; 173(17):5290-7. PubMed ID: 1832151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative genomic analyses of two novel qnrVC6 carrying multidrug-resistant Pseudomonas. spp strains.
    Liu J; Yang L; Li L; Li B; Chen D; Xu Z
    Microb Pathog; 2018 Oct; 123():269-274. PubMed ID: 30041000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emergence and persistence of integron structures harbouring VIM genes in the Children's Memorial Health Institute, Warsaw, Poland, 1998-2006.
    Patzer JA; Walsh TR; Weeks J; Dzierzanowska D; Toleman MA
    J Antimicrob Chemother; 2009 Feb; 63(2):269-73. PubMed ID: 19095681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First detection in Europe of the metallo-β-lactamase IMP-15 in clinical strains of Pseudomonas putida and Pseudomonas aeruginosa.
    Gilarranz R; Juan C; Castillo-Vera J; Chamizo FJ; Artiles F; Álamo I; Oliver A
    Clin Microbiol Infect; 2013 Sep; 19(9):E424-7. PubMed ID: 23656535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.